

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 5.85633834 |
| 2 | actin-myosin filament sliding (GO:0033275) | 5.85633834 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.62431004 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.62431004 |
| 5 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.35479602 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.34987650 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.34987650 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.10746478 |
| 9 | actin-mediated cell contraction (GO:0070252) | 5.07632642 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 4.91883388 |
| 11 | lysine catabolic process (GO:0006554) | 4.81798449 |
| 12 | lysine metabolic process (GO:0006553) | 4.81798449 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.80941698 |
| 14 | skeletal muscle contraction (GO:0003009) | 4.79058937 |
| 15 | glyoxylate metabolic process (GO:0046487) | 4.76045281 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 4.72661167 |
| 17 | cysteine metabolic process (GO:0006534) | 4.68281600 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.65413163 |
| 19 | homocysteine metabolic process (GO:0050667) | 4.64832852 |
| 20 | skeletal muscle adaptation (GO:0043501) | 4.51119983 |
| 21 | bile acid biosynthetic process (GO:0006699) | 4.46480411 |
| 22 | phospholipid homeostasis (GO:0055091) | 4.42775378 |
| 23 | urea metabolic process (GO:0019627) | 4.40123944 |
| 24 | urea cycle (GO:0000050) | 4.40123944 |
| 25 | kynurenine metabolic process (GO:0070189) | 4.34676339 |
| 26 | indolalkylamine catabolic process (GO:0046218) | 4.32819613 |
| 27 | tryptophan catabolic process (GO:0006569) | 4.32819613 |
| 28 | indole-containing compound catabolic process (GO:0042436) | 4.32819613 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.31295409 |
| 30 | tryptophan metabolic process (GO:0006568) | 4.25415966 |
| 31 | sarcomere organization (GO:0045214) | 4.22562514 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 4.21941604 |
| 33 | actin filament-based movement (GO:0030048) | 4.21151427 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.21016072 |
| 35 | protein carboxylation (GO:0018214) | 4.21016072 |
| 36 | glycogen catabolic process (GO:0005980) | 4.08964345 |
| 37 | amino-acid betaine metabolic process (GO:0006577) | 4.08256905 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.04961194 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 3.97706372 |
| 40 | fatty acid transmembrane transport (GO:1902001) | 3.97701919 |
| 41 | cellular ketone body metabolic process (GO:0046950) | 3.96628731 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 3.92328190 |
| 43 | bile acid metabolic process (GO:0008206) | 3.90352231 |
| 44 | negative regulation of fibrinolysis (GO:0051918) | 3.89588986 |
| 45 | regulation of complement activation (GO:0030449) | 3.86252137 |
| 46 | glucan catabolic process (GO:0009251) | 3.83491204 |
| 47 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.82412870 |
| 48 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.81895842 |
| 49 | plasma lipoprotein particle clearance (GO:0034381) | 3.79657681 |
| 50 | response to muscle activity (GO:0014850) | 3.77600241 |
| 51 | high-density lipoprotein particle remodeling (GO:0034375) | 3.77115507 |
| 52 | regulation of skeletal muscle contraction (GO:0014819) | 3.76340897 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 3.74299990 |
| 54 | fatty acid beta-oxidation (GO:0006635) | 3.72294214 |
| 55 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.71403514 |
| 56 | short-chain fatty acid metabolic process (GO:0046459) | 3.70503242 |
| 57 | NADH metabolic process (GO:0006734) | 3.69765202 |
| 58 | myofibril assembly (GO:0030239) | 3.68715110 |
| 59 | 2-oxoglutarate metabolic process (GO:0006103) | 3.68323553 |
| 60 | cellular polysaccharide catabolic process (GO:0044247) | 3.67181983 |
| 61 | striated muscle contraction (GO:0006941) | 3.67155273 |
| 62 | drug catabolic process (GO:0042737) | 3.65621847 |
| 63 | striated muscle atrophy (GO:0014891) | 3.65602586 |
| 64 | phospholipid efflux (GO:0033700) | 3.63973667 |
| 65 | carnitine shuttle (GO:0006853) | 3.63298938 |
| 66 | cellular glucuronidation (GO:0052695) | 3.62525934 |
| 67 | regulation of fibrinolysis (GO:0051917) | 3.62437978 |
| 68 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.59939733 |
| 69 | aspartate family amino acid catabolic process (GO:0009068) | 3.59529115 |
| 70 | reverse cholesterol transport (GO:0043691) | 3.59378759 |
| 71 | alpha-amino acid catabolic process (GO:1901606) | 3.59269423 |
| 72 | regulation of sequestering of triglyceride (GO:0010889) | 3.58059218 |
| 73 | regulation of relaxation of muscle (GO:1901077) | 3.57272147 |
| 74 | cardiac muscle hypertrophy (GO:0003300) | 3.55067149 |
| 75 | fatty acid oxidation (GO:0019395) | 3.54982943 |
| 76 | tyrosine metabolic process (GO:0006570) | 3.53996564 |
| 77 | creatine metabolic process (GO:0006600) | 3.52648695 |
| 78 | glutamate metabolic process (GO:0006536) | 3.51355054 |
| 79 | drug transmembrane transport (GO:0006855) | 3.50831126 |
| 80 | lipid oxidation (GO:0034440) | 3.49050702 |
| 81 | acetyl-CoA metabolic process (GO:0006084) | 3.48474681 |
| 82 | cellular modified amino acid catabolic process (GO:0042219) | 3.47696769 |
| 83 | valine metabolic process (GO:0006573) | 3.47603962 |
| 84 | cholesterol efflux (GO:0033344) | 3.46553821 |
| 85 | aromatic amino acid family metabolic process (GO:0009072) | 3.46338735 |
| 86 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.44715145 |
| 87 | acylglycerol homeostasis (GO:0055090) | 3.44359999 |
| 88 | triglyceride homeostasis (GO:0070328) | 3.44359999 |
| 89 | cellular amino acid catabolic process (GO:0009063) | 3.42215520 |
| 90 | ethanol oxidation (GO:0006069) | 3.41545871 |
| 91 | ketone body metabolic process (GO:1902224) | 3.40300007 |
| 92 | striated muscle adaptation (GO:0014888) | 3.39616565 |
| 93 | fatty acid catabolic process (GO:0009062) | 3.38823203 |
| 94 | regulation of cholesterol homeostasis (GO:2000188) | 3.36615111 |
| 95 | striated muscle hypertrophy (GO:0014897) | 3.35620934 |
| 96 | urate metabolic process (GO:0046415) | 3.34222212 |
| 97 | carnitine metabolic process (GO:0009437) | 3.34127836 |
| 98 | monocarboxylic acid catabolic process (GO:0072329) | 3.33574137 |
| 99 | exogenous drug catabolic process (GO:0042738) | 3.33466266 |
| 100 | COPII vesicle coating (GO:0048208) | 3.33301317 |
| 101 | plasma lipoprotein particle remodeling (GO:0034369) | 3.31081674 |
| 102 | protein-lipid complex remodeling (GO:0034368) | 3.31081674 |
| 103 | macromolecular complex remodeling (GO:0034367) | 3.31081674 |
| 104 | muscle atrophy (GO:0014889) | 3.30340205 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.28463864 |
| 106 | uronic acid metabolic process (GO:0006063) | 3.26741598 |
| 107 | glucuronate metabolic process (GO:0019585) | 3.26741598 |
| 108 | actomyosin structure organization (GO:0031032) | 3.25429672 |
| 109 | polysaccharide catabolic process (GO:0000272) | 3.24917623 |
| 110 | plasma lipoprotein particle assembly (GO:0034377) | 3.24779214 |
| 111 | organic acid catabolic process (GO:0016054) | 3.18057874 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.18057874 |
| 113 | negative regulation of cholesterol transport (GO:0032375) | 3.17813434 |
| 114 | negative regulation of sterol transport (GO:0032372) | 3.17813434 |
| 115 | regulation of cholesterol esterification (GO:0010872) | 3.17167701 |
| 116 | protein-lipid complex assembly (GO:0065005) | 3.15788351 |
| 117 | bile acid and bile salt transport (GO:0015721) | 3.14722599 |
| 118 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.11278386 |
| 119 | amino-acid betaine transport (GO:0015838) | 3.11151634 |
| 120 | carnitine transport (GO:0015879) | 3.11151634 |
| 121 | positive regulation of fatty acid oxidation (GO:0046321) | 3.10925591 |
| 122 | sterol homeostasis (GO:0055092) | 3.10682758 |
| 123 | cholesterol homeostasis (GO:0042632) | 3.10673140 |
| 124 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.10534559 |
| 125 | benzene-containing compound metabolic process (GO:0042537) | 3.08415715 |
| 126 | low-density lipoprotein particle clearance (GO:0034383) | 3.07261942 |
| 127 | lipoprotein metabolic process (GO:0042157) | 3.07209127 |
| 128 | cardiac muscle contraction (GO:0060048) | 3.07117120 |
| 129 | serine family amino acid metabolic process (GO:0009069) | 3.06854330 |
| 130 | coenzyme catabolic process (GO:0009109) | 3.06832427 |
| 131 | regulation of bile acid biosynthetic process (GO:0070857) | 3.04959806 |
| 132 | indolalkylamine metabolic process (GO:0006586) | 3.03353893 |
| 133 | cardiac myofibril assembly (GO:0055003) | 3.02900809 |
| 134 | muscle contraction (GO:0006936) | 2.96445898 |
| 135 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.96270781 |
| 136 | regulation of actin filament-based movement (GO:1903115) | 2.94337523 |
| 137 | carnitine transmembrane transport (GO:1902603) | 2.94025164 |
| 138 | intestinal epithelial cell development (GO:0060576) | 2.91762695 |
| 139 | muscle hypertrophy (GO:0014896) | 2.90687165 |
| 140 | negative regulation of protein activation cascade (GO:2000258) | 2.87041933 |
| 141 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.86622868 |
| 142 | muscle hypertrophy in response to stress (GO:0003299) | 2.86622868 |
| 143 | cardiac muscle adaptation (GO:0014887) | 2.86622868 |
| 144 | blood coagulation, intrinsic pathway (GO:0007597) | 2.85590219 |
| 145 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.85254118 |
| 146 | fructose metabolic process (GO:0006000) | 2.84943124 |
| 147 | glycogen biosynthetic process (GO:0005978) | 2.80828574 |
| 148 | glucan biosynthetic process (GO:0009250) | 2.80828574 |
| 149 | macroautophagy (GO:0016236) | 2.80453433 |
| 150 | intracellular lipid transport (GO:0032365) | 2.79671785 |
| 151 | peptidyl-lysine dimethylation (GO:0018027) | 2.74600172 |
| 152 | glycogen metabolic process (GO:0005977) | 2.74391049 |
| 153 | epoxygenase P450 pathway (GO:0019373) | 2.71331223 |
| 154 | cellular carbohydrate catabolic process (GO:0044275) | 2.70673085 |
| 155 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.68660568 |
| 156 | glucan metabolic process (GO:0044042) | 2.68567443 |
| 157 | cellular glucan metabolic process (GO:0006073) | 2.68567443 |
| 158 | muscle adaptation (GO:0043500) | 2.66339128 |
| 159 | muscle system process (GO:0003012) | 2.66226283 |
| 160 | growth hormone receptor signaling pathway (GO:0060396) | 2.64133135 |
| 161 | biotin metabolic process (GO:0006768) | 2.63737476 |
| 162 | desmosome organization (GO:0002934) | 2.63470294 |
| 163 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.60919682 |
| 164 | regulation of establishment of cell polarity (GO:2000114) | 2.59922850 |
| 165 | positive regulation of hormone metabolic process (GO:0032352) | 2.55857498 |
| 166 | regulation of cell communication by electrical coupling (GO:0010649) | 2.53272638 |
| 167 | negative regulation of complement activation (GO:0045916) | 2.52845811 |
| 168 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.51810438 |
| 169 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.51686891 |
| 170 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.50011113 |
| 171 | quaternary ammonium group transport (GO:0015697) | 2.49651086 |
| 172 | tricarboxylic acid cycle (GO:0006099) | 2.49339595 |
| 173 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.48115975 |
| 174 | hepatocyte apoptotic process (GO:0097284) | 2.47959535 |
| 175 | response to inactivity (GO:0014854) | 2.47435389 |
| 176 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.45274810 |
| 177 | cell-substrate adherens junction assembly (GO:0007045) | 2.45241435 |
| 178 | focal adhesion assembly (GO:0048041) | 2.45241435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.90705258 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.78003337 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.04176941 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.98763498 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.37320581 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.00411704 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.55621286 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.39110107 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.53387492 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.42408938 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.39449224 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.37599436 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.20600331 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.88058672 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.79873892 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78938571 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.78522716 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.75235300 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.73833427 |
| 20 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.71979100 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70692833 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70314571 |
| 23 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.69000216 |
| 24 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63450222 |
| 25 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.60630921 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59008084 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58947474 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.53984237 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52849921 |
| 30 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.52757415 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.52630736 |
| 32 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.46440218 |
| 33 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.46440218 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45970853 |
| 35 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.45683021 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40833040 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.40604981 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40341306 |
| 39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.38068844 |
| 40 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.37245684 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35171197 |
| 42 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.34997047 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33216201 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30643073 |
| 45 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30566510 |
| 46 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.29755283 |
| 47 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.28266400 |
| 48 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26437638 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.25215987 |
| 50 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21996736 |
| 51 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.21410215 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19544544 |
| 53 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19345875 |
| 54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19292561 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17362844 |
| 56 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.17165691 |
| 57 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16166764 |
| 58 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16166764 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.15782931 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15545215 |
| 61 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12682280 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.12216574 |
| 63 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11353702 |
| 64 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10307444 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09844093 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09442695 |
| 67 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08831645 |
| 68 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07872251 |
| 69 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07420769 |
| 70 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06643991 |
| 71 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06239151 |
| 72 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.05185462 |
| 73 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05007846 |
| 74 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.04614975 |
| 75 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02137991 |
| 76 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.01831074 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.01141083 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00818111 |
| 79 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.00206880 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98425294 |
| 81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98261498 |
| 82 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.95790318 |
| 83 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95635510 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95074576 |
| 85 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94193243 |
| 86 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.94142174 |
| 87 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93513326 |
| 88 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93374931 |
| 89 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93249837 |
| 90 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93159159 |
| 91 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92877705 |
| 92 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92294580 |
| 93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91262909 |
| 94 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.90261206 |
| 95 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90172615 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.89971295 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89638918 |
| 98 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89225648 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88330061 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87616626 |
| 101 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.84971852 |
| 102 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84733146 |
| 103 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.84214087 |
| 104 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84141075 |
| 105 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83687915 |
| 106 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.83432165 |
| 107 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83207338 |
| 108 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.82614730 |
| 109 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82369438 |
| 110 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82216333 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80623176 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78350744 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77785104 |
| 114 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77667946 |
| 115 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.76616312 |
| 116 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.76126432 |
| 117 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.75317237 |
| 118 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.75261936 |
| 119 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.75082525 |
| 120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75047967 |
| 121 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74992519 |
| 122 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74594215 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.74576306 |
| 124 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.73405661 |
| 125 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.72974133 |
| 126 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72031884 |
| 127 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.72005272 |
| 128 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.71957506 |
| 129 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.71904459 |
| 130 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.71904459 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.71199707 |
| 132 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.70526121 |
| 133 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68544233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.42442040 |
| 2 | MP0005360_urolithiasis | 6.19258780 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.73038848 |
| 4 | MP0005365_abnormal_bile_salt | 4.56229989 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.79792502 |
| 6 | MP0003252_abnormal_bile_duct | 3.33306575 |
| 7 | MP0005083_abnormal_biliary_tract | 2.93620343 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.90732921 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.86821973 |
| 10 | MP0009840_abnormal_foam_cell | 2.86004613 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.72511961 |
| 12 | MP0005332_abnormal_amino_acid | 2.47065676 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.44597225 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.40988055 |
| 15 | MP0004130_abnormal_muscle_cell | 2.39663905 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.32782808 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.18093476 |
| 18 | MP0004484_altered_response_of | 2.17600200 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.14004236 |
| 20 | MP0006138_congestive_heart_failure | 2.05887178 |
| 21 | MP0003195_calcinosis | 2.04938942 |
| 22 | MP0004264_abnormal_extraembryonic_tissu | 2.03835126 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.03106792 |
| 24 | MP0001666_abnormal_nutrient_absorption | 1.99485802 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.95016748 |
| 26 | MP0003828_pulmonary_edema | 1.94458910 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.89732216 |
| 28 | MP0002009_preneoplasia | 1.86805173 |
| 29 | MP0000609_abnormal_liver_physiology | 1.86280524 |
| 30 | MP0003941_abnormal_skin_development | 1.85167039 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.82416471 |
| 32 | MP0003221_abnormal_cardiomyocyte_apopto | 1.70047925 |
| 33 | MP0008438_abnormal_cutaneous_collagen | 1.68429891 |
| 34 | MP0002127_abnormal_cardiovascular_syste | 1.56121933 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.53727429 |
| 36 | MP0003690_abnormal_glial_cell | 1.50499260 |
| 37 | MP0005670_abnormal_white_adipose | 1.46756599 |
| 38 | MP0002796_impaired_skin_barrier | 1.44699268 |
| 39 | MP0002254_reproductive_system_inflammat | 1.43700240 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42533836 |
| 41 | MP0005666_abnormal_adipose_tissue | 1.41635162 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.39163272 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.36222354 |
| 44 | MP0000604_amyloidosis | 1.35010230 |
| 45 | MP0003890_abnormal_embryonic-extraembry | 1.32312501 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.32254279 |
| 47 | MP0000747_muscle_weakness | 1.29091753 |
| 48 | MP0000749_muscle_degeneration | 1.26340023 |
| 49 | MP0010678_abnormal_skin_adnexa | 1.24040891 |
| 50 | MP0000750_abnormal_muscle_regeneration | 1.22318577 |
| 51 | MP0000383_abnormal_hair_follicle | 1.20880694 |
| 52 | MP0000751_myopathy | 1.20407646 |
| 53 | MP0002971_abnormal_brown_adipose | 1.13657596 |
| 54 | MP0005275_abnormal_skin_tensile | 1.13531940 |
| 55 | MP0004510_myositis | 1.12665736 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.11572835 |
| 57 | MP0001958_emphysema | 1.10332676 |
| 58 | MP0002269_muscular_atrophy | 1.09398828 |
| 59 | MP0003646_muscle_fatigue | 1.07694366 |
| 60 | MP0008057_abnormal_DNA_replication | 1.06772477 |
| 61 | MP0004087_abnormal_muscle_fiber | 1.04165633 |
| 62 | MP0003186_abnormal_redox_activity | 1.03527775 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.03395222 |
| 64 | MP0008260_abnormal_autophagy | 1.02848707 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 1.01436888 |
| 66 | MP0010368_abnormal_lymphatic_system | 0.99579107 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 0.99453674 |
| 68 | MP0003868_abnormal_feces_composition | 0.99327839 |
| 69 | MP0004036_abnormal_muscle_relaxation | 0.98932919 |
| 70 | MP0000598_abnormal_liver_morphology | 0.98695146 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 0.96955482 |
| 72 | MP0005076_abnormal_cell_differentiation | 0.96844901 |
| 73 | MP0001756_abnormal_urination | 0.93209157 |
| 74 | MP0009764_decreased_sensitivity_to | 0.92505360 |
| 75 | MP0003183_abnormal_peptide_metabolism | 0.92103188 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.91965636 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.89072986 |
| 78 | MP0005409_darkened_coat_color | 0.87038733 |
| 79 | MP0008775_abnormal_heart_ventricle | 0.86966841 |
| 80 | MP0009763_increased_sensitivity_to | 0.86709441 |
| 81 | MP0000266_abnormal_heart_morphology | 0.86116910 |
| 82 | MP0003011_delayed_dark_adaptation | 0.84791749 |
| 83 | MP0005334_abnormal_fat_pad | 0.84535403 |
| 84 | MP0005647_abnormal_sex_gland | 0.83439149 |
| 85 | MP0004381_abnormal_hair_follicle | 0.83247699 |
| 86 | MP0006054_spinal_hemorrhage | 0.82745322 |
| 87 | MP0002128_abnormal_blood_circulation | 0.81851767 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.81003357 |
| 89 | MP0001727_abnormal_embryo_implantation | 0.80923478 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.80186451 |
| 91 | MP0009672_abnormal_birth_weight | 0.79281546 |
| 92 | MP0002088_abnormal_embryonic_growth/wei | 0.78968179 |
| 93 | MP0008004_abnormal_stomach_pH | 0.78879614 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.78747001 |
| 95 | MP0002168_other_aberrant_phenotype | 0.78290521 |
| 96 | MP0005375_adipose_tissue_phenotype | 0.78117084 |
| 97 | MP0000627_abnormal_mammary_gland | 0.77579203 |
| 98 | MP0004043_abnormal_pH_regulation | 0.76699267 |
| 99 | MP0001764_abnormal_homeostasis | 0.76524293 |
| 100 | MP0005451_abnormal_body_composition | 0.75774562 |
| 101 | MP0003984_embryonic_growth_retardation | 0.75237365 |
| 102 | MP0005620_abnormal_muscle_contractility | 0.74862181 |
| 103 | MP0004085_abnormal_heartbeat | 0.74616643 |
| 104 | MP0008469_abnormal_protein_level | 0.74393304 |
| 105 | MP0010234_abnormal_vibrissa_follicle | 0.73832313 |
| 106 | MP0005636_abnormal_mineral_homeostasis | 0.73820683 |
| 107 | MP0005330_cardiomyopathy | 0.73357516 |
| 108 | MP0006036_abnormal_mitochondrial_physio | 0.72149793 |
| 109 | MP0009697_abnormal_copulation | 0.71746120 |
| 110 | MP0000003_abnormal_adipose_tissue | 0.70913858 |
| 111 | MP0005408_hypopigmentation | 0.70701277 |
| 112 | MP0002896_abnormal_bone_mineralization | 0.70169746 |
| 113 | MP0003950_abnormal_plasma_membrane | 0.69740961 |
| 114 | MP0004272_abnormal_basement_membrane | 0.69530137 |
| 115 | MP0000427_abnormal_hair_cycle | 0.68940848 |
| 116 | MP0001915_intracranial_hemorrhage | 0.68525567 |
| 117 | MP0002106_abnormal_muscle_physiology | 0.68036194 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.67688400 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.67055667 |
| 120 | MP0009115_abnormal_fat_cell | 0.67032783 |
| 121 | MP0009642_abnormal_blood_homeostasis | 0.65771913 |
| 122 | MP0000759_abnormal_skeletal_muscle | 0.65531453 |
| 123 | MP0001661_extended_life_span | 0.65202848 |
| 124 | MP0010630_abnormal_cardiac_muscle | 0.65112413 |
| 125 | MP0002060_abnormal_skin_morphology | 0.61258535 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.60750969 |
| 127 | MP0005166_decreased_susceptibility_to | 0.57135430 |
| 128 | MP0005369_muscle_phenotype | 0.56071532 |
| 129 | MP0000733_abnormal_muscle_development | 0.55009291 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.54980779 |
| 131 | MP0002108_abnormal_muscle_morphology | 0.52538238 |
| 132 | MP0003045_fibrosis | 0.52307727 |
| 133 | MP0000371_diluted_coat_color | 0.52109169 |
| 134 | MP0009384_cardiac_valve_regurgitation | 0.52013679 |
| 135 | MP0005376_homeostasis/metabolism_phenot | 0.51723190 |
| 136 | MP0001544_abnormal_cardiovascular_syste | 0.51166759 |
| 137 | MP0005385_cardiovascular_system_phenoty | 0.51166759 |
| 138 | MP0004084_abnormal_cardiac_muscle | 0.50741941 |
| 139 | MP0006082_CNS_inflammation | 0.50121544 |
| 140 | MP0004233_abnormal_muscle_weight | 0.50063559 |
| 141 | MP0005266_abnormal_metabolism | 0.49803133 |
| 142 | MP0005535_abnormal_body_temperature | 0.49178371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.12727904 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.10252804 |
| 3 | Complement deficiency (HP:0004431) | 4.88703780 |
| 4 | Xanthomatosis (HP:0000991) | 4.85435675 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.29725493 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.21580251 |
| 7 | Hypoalphalipoproteinemia (HP:0003233) | 4.11937129 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 3.86360298 |
| 9 | EMG: myopathic abnormalities (HP:0003458) | 3.86124279 |
| 10 | Bundle branch block (HP:0011710) | 3.76587641 |
| 11 | Hyperammonemia (HP:0001987) | 3.74872846 |
| 12 | Hypolipoproteinemia (HP:0010981) | 3.73380082 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.69460986 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 3.69048774 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.67090433 |
| 16 | Ketosis (HP:0001946) | 3.66717947 |
| 17 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.66421416 |
| 18 | Subaortic stenosis (HP:0001682) | 3.66421416 |
| 19 | Epidermoid cyst (HP:0200040) | 3.61008861 |
| 20 | Abnormality of complement system (HP:0005339) | 3.55938035 |
| 21 | Hyperglycinuria (HP:0003108) | 3.50782415 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.47673708 |
| 23 | Prolonged partial thromboplastin time (HP:0003645) | 3.39472974 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.38745330 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.38745330 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 3.36478552 |
| 27 | Myocardial infarction (HP:0001658) | 3.36267947 |
| 28 | Neck muscle weakness (HP:0000467) | 3.33960705 |
| 29 | Sudden death (HP:0001699) | 3.32124100 |
| 30 | Rimmed vacuoles (HP:0003805) | 3.31135603 |
| 31 | Hyperglycinemia (HP:0002154) | 3.30091279 |
| 32 | Exercise-induced muscle cramps (HP:0003710) | 3.28880529 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.27211830 |
| 34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.23159088 |
| 35 | Gout (HP:0001997) | 3.21871617 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.19317977 |
| 37 | Joint hemorrhage (HP:0005261) | 3.17520855 |
| 38 | Abnormality of purine metabolism (HP:0004352) | 3.15117161 |
| 39 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.10508362 |
| 40 | Exercise-induced myalgia (HP:0003738) | 3.05580510 |
| 41 | Ventricular tachycardia (HP:0004756) | 3.04685172 |
| 42 | Hypercholesterolemia (HP:0003124) | 3.04496176 |
| 43 | Hypoglycemic coma (HP:0001325) | 3.00381198 |
| 44 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.98311910 |
| 45 | Abnormality of the common coagulation pathway (HP:0010990) | 2.96760166 |
| 46 | Ketoacidosis (HP:0001993) | 2.86996590 |
| 47 | Myoglobinuria (HP:0002913) | 2.84487627 |
| 48 | Fat malabsorption (HP:0002630) | 2.83097542 |
| 49 | Myopathic facies (HP:0002058) | 2.82356247 |
| 50 | Hyperkalemia (HP:0002153) | 2.82005043 |
| 51 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.80425405 |
| 52 | Skin nodule (HP:0200036) | 2.74282487 |
| 53 | Glomerulonephritis (HP:0000099) | 2.74121305 |
| 54 | Testicular neoplasm (HP:0010788) | 2.73654490 |
| 55 | Papillary thyroid carcinoma (HP:0002895) | 2.73392148 |
| 56 | Abnormality of methionine metabolism (HP:0010901) | 2.72284993 |
| 57 | Abnormality of nucleobase metabolism (HP:0010932) | 2.71577038 |
| 58 | EMG: neuropathic changes (HP:0003445) | 2.69984472 |
| 59 | Hyperuricemia (HP:0002149) | 2.64338307 |
| 60 | Increased purine levels (HP:0004368) | 2.64338307 |
| 61 | Hyporeflexia of lower limbs (HP:0002600) | 2.61443286 |
| 62 | Areflexia of lower limbs (HP:0002522) | 2.55598726 |
| 63 | Hepatocellular carcinoma (HP:0001402) | 2.54471564 |
| 64 | Muscle fiber inclusion bodies (HP:0100299) | 2.54430876 |
| 65 | Round ear (HP:0100830) | 2.49012422 |
| 66 | Frequent falls (HP:0002359) | 2.48679317 |
| 67 | Axonal loss (HP:0003447) | 2.47947045 |
| 68 | Esophageal varix (HP:0002040) | 2.47057058 |
| 69 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.39271406 |
| 70 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.35979179 |
| 71 | Vascular calcification (HP:0004934) | 2.35742141 |
| 72 | Dilated cardiomyopathy (HP:0001644) | 2.35572002 |
| 73 | Increased connective tissue (HP:0009025) | 2.35229770 |
| 74 | Abnormality of the intrinsic pathway (HP:0010989) | 2.31865118 |
| 75 | Hydroxyprolinuria (HP:0003080) | 2.31076756 |
| 76 | Abnormality of proline metabolism (HP:0010907) | 2.31076756 |
| 77 | Metabolic acidosis (HP:0001942) | 2.29768128 |
| 78 | Increased variability in muscle fiber diameter (HP:0003557) | 2.29679019 |
| 79 | Heart block (HP:0012722) | 2.29657787 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.26416661 |
| 81 | Rhabdomyolysis (HP:0003201) | 2.26279366 |
| 82 | Difficulty running (HP:0009046) | 2.23815888 |
| 83 | Conjugated hyperbilirubinemia (HP:0002908) | 2.22958401 |
| 84 | Sensorimotor neuropathy (HP:0007141) | 2.20767450 |
| 85 | Abnormality of serum amino acid levels (HP:0003112) | 2.20381673 |
| 86 | Dicarboxylic aciduria (HP:0003215) | 2.18824484 |
| 87 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.18824484 |
| 88 | Nephritis (HP:0000123) | 2.17515606 |
| 89 | Bulbar palsy (HP:0001283) | 2.16744092 |
| 90 | Peripheral demyelination (HP:0011096) | 2.16264567 |
| 91 | Nemaline bodies (HP:0003798) | 2.13673935 |
| 92 | Termporal pattern (HP:0011008) | 2.13185901 |
| 93 | Insidious onset (HP:0003587) | 2.13185901 |
| 94 | Proximal tubulopathy (HP:0000114) | 2.12932895 |
| 95 | Asymmetric septal hypertrophy (HP:0001670) | 2.12811398 |
| 96 | Abnormal atrioventricular conduction (HP:0005150) | 2.12319699 |
| 97 | Type 1 muscle fiber predominance (HP:0003803) | 2.10952828 |
| 98 | Steatorrhea (HP:0002570) | 2.10447503 |
| 99 | Increased CSF protein (HP:0002922) | 2.09030256 |
| 100 | Tetraparesis (HP:0002273) | 2.07379155 |
| 101 | Atrioventricular block (HP:0001678) | 2.07112871 |
| 102 | Lipoatrophy (HP:0100578) | 2.06610314 |
| 103 | Muscle fiber splitting (HP:0003555) | 2.06456739 |
| 104 | Spastic diplegia (HP:0001264) | 2.03738162 |
| 105 | Germ cell neoplasia (HP:0100728) | 2.03312993 |
| 106 | Cholelithiasis (HP:0001081) | 2.03029668 |
| 107 | Delayed CNS myelination (HP:0002188) | 2.01938637 |
| 108 | Hypochromic microcytic anemia (HP:0004840) | 2.01693101 |
| 109 | Gonadal dysgenesis (HP:0000133) | 2.01417260 |
| 110 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00551171 |
| 111 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.99488584 |
| 112 | Hyperbilirubinemia (HP:0002904) | 1.99101560 |
| 113 | Amyloidosis (HP:0011034) | 1.93690320 |
| 114 | Flat acetabular roof (HP:0003180) | 1.92979607 |
| 115 | Abnormal gallbladder morphology (HP:0012437) | 1.92741229 |
| 116 | Abnormality of the Achilles tendon (HP:0005109) | 1.91838510 |
| 117 | Scapular winging (HP:0003691) | 1.91446694 |
| 118 | Ventricular arrhythmia (HP:0004308) | 1.90061824 |
| 119 | Absent phalangeal crease (HP:0006109) | 1.89918267 |
| 120 | Protuberant abdomen (HP:0001538) | 1.89883613 |
| 121 | Microglossia (HP:0000171) | 1.86934630 |
| 122 | Distal lower limb muscle weakness (HP:0009053) | 1.86915297 |
| 123 | Upper motor neuron abnormality (HP:0002127) | 1.85991188 |
| 124 | Generalized aminoaciduria (HP:0002909) | 1.84735860 |
| 125 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.84496792 |
| 126 | Right ventricular cardiomyopathy (HP:0011663) | 1.84345589 |
| 127 | Malignant hyperthermia (HP:0002047) | 1.83284406 |
| 128 | Arterial tortuosity (HP:0005116) | 1.83088835 |
| 129 | Muscle stiffness (HP:0003552) | 1.82808666 |
| 130 | Vacuolated lymphocytes (HP:0001922) | 1.82021594 |
| 131 | Mitral stenosis (HP:0001718) | 1.80967381 |
| 132 | Malnutrition (HP:0004395) | 1.80701668 |
| 133 | Abnormality of iron homeostasis (HP:0011031) | 1.79811684 |
| 134 | Distal arthrogryposis (HP:0005684) | 1.78076045 |
| 135 | Spontaneous abortion (HP:0005268) | 1.77857829 |
| 136 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.77158424 |
| 137 | Hemorrhage of the eye (HP:0011885) | 1.76439468 |
| 138 | Ulnar deviation of the wrist (HP:0003049) | 1.75627005 |
| 139 | Global brain atrophy (HP:0002283) | 1.72821791 |
| 140 | Abnormal finger flexion creases (HP:0006143) | 1.72652033 |
| 141 | Vomiting (HP:0002013) | 1.72650973 |
| 142 | Curly hair (HP:0002212) | 1.70038847 |
| 143 | Menorrhagia (HP:0000132) | 1.68817079 |
| 144 | Gowers sign (HP:0003391) | 1.66116652 |
| 145 | Back pain (HP:0003418) | 1.65605911 |
| 146 | Palpitations (HP:0001962) | 1.65167042 |
| 147 | Distal lower limb amyotrophy (HP:0008944) | 1.64794928 |
| 148 | Hyperphosphatemia (HP:0002905) | 1.62665342 |
| 149 | Progressive external ophthalmoplegia (HP:0000590) | 1.60665934 |
| 150 | Skin pits (HP:0100276) | 1.59268772 |
| 151 | Progressive muscle weakness (HP:0003323) | 1.58818576 |
| 152 | Abnormal tarsal ossification (HP:0008369) | 1.58730415 |
| 153 | Biliary tract neoplasm (HP:0100574) | 1.58467307 |
| 154 | Thyroid carcinoma (HP:0002890) | 1.58425543 |
| 155 | Hypoplastic left heart (HP:0004383) | 1.57646785 |
| 156 | Dysmetric saccades (HP:0000641) | 1.57166016 |
| 157 | Sparse lateral eyebrow (HP:0005338) | 1.56521586 |
| 158 | Generalized muscle weakness (HP:0003324) | 1.54615346 |
| 159 | Osteomalacia (HP:0002749) | 1.53208839 |
| 160 | Gonadotropin excess (HP:0000837) | 1.53017071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.53489178 |
| 2 | BCKDK | 3.42179343 |
| 3 | OBSCN | 2.76087514 |
| 4 | CAMK1D | 2.72358430 |
| 5 | LATS1 | 2.56984033 |
| 6 | TRIB3 | 2.49729891 |
| 7 | SIK1 | 2.33579997 |
| 8 | NEK9 | 2.25014347 |
| 9 | MAPKAPK3 | 2.17766757 |
| 10 | FRK | 2.17026025 |
| 11 | MAP3K12 | 2.14073176 |
| 12 | CAMK1G | 2.06001652 |
| 13 | PKN2 | 1.97301359 |
| 14 | ERN1 | 1.93893403 |
| 15 | MAP2K3 | 1.85831054 |
| 16 | RIPK1 | 1.83264074 |
| 17 | SIK3 | 1.79782267 |
| 18 | PHKG1 | 1.79618109 |
| 19 | PHKG2 | 1.79618109 |
| 20 | STK24 | 1.76309781 |
| 21 | PIK3CG | 1.76063092 |
| 22 | PTK6 | 1.73479058 |
| 23 | FGFR4 | 1.71248346 |
| 24 | TGFBR2 | 1.70151957 |
| 25 | MST4 | 1.69348920 |
| 26 | EEF2K | 1.61743435 |
| 27 | AKT3 | 1.58454712 |
| 28 | MAP3K3 | 1.55801354 |
| 29 | TYK2 | 1.54427417 |
| 30 | TAOK3 | 1.49526546 |
| 31 | MAP3K7 | 1.48607840 |
| 32 | LMTK2 | 1.44201555 |
| 33 | MAP2K4 | 1.43662514 |
| 34 | CDK6 | 1.43474294 |
| 35 | INSRR | 1.39677776 |
| 36 | NLK | 1.39518439 |
| 37 | NEK6 | 1.39108509 |
| 38 | PIK3CA | 1.37536183 |
| 39 | PDK4 | 1.37396618 |
| 40 | PDK3 | 1.37396618 |
| 41 | ERBB3 | 1.35557658 |
| 42 | EPHB1 | 1.34196329 |
| 43 | MYLK | 1.29986370 |
| 44 | TRIM28 | 1.29211096 |
| 45 | EIF2AK3 | 1.28757365 |
| 46 | EPHA2 | 1.26954163 |
| 47 | PRKAA2 | 1.24139808 |
| 48 | WNK4 | 1.23103777 |
| 49 | ERBB4 | 1.20441708 |
| 50 | JAK1 | 1.16038854 |
| 51 | SGK3 | 1.14682157 |
| 52 | ACVR1B | 1.14569934 |
| 53 | FGFR2 | 1.11275717 |
| 54 | STK39 | 1.06730958 |
| 55 | MST1R | 1.06509219 |
| 56 | MAP3K2 | 1.06426842 |
| 57 | DAPK2 | 1.01377142 |
| 58 | SCYL2 | 0.99978392 |
| 59 | NEK1 | 0.99971252 |
| 60 | MAPK12 | 0.98543663 |
| 61 | MUSK | 0.97214439 |
| 62 | STK38 | 0.96515993 |
| 63 | JAK2 | 0.96217447 |
| 64 | RPS6KB2 | 0.96044584 |
| 65 | WNK1 | 0.92960232 |
| 66 | CDK12 | 0.92597099 |
| 67 | STK3 | 0.92210966 |
| 68 | PDK2 | 0.90055983 |
| 69 | MET | 0.90032475 |
| 70 | MAPK11 | 0.88540095 |
| 71 | YES1 | 0.86587039 |
| 72 | FGFR3 | 0.85241428 |
| 73 | PRKAA1 | 0.82552390 |
| 74 | BRSK2 | 0.82549787 |
| 75 | DMPK | 0.82531110 |
| 76 | SGK2 | 0.79485594 |
| 77 | OXSR1 | 0.79250150 |
| 78 | RPS6KB1 | 0.78680055 |
| 79 | PDGFRA | 0.77077251 |
| 80 | GSK3A | 0.76958163 |
| 81 | STK38L | 0.75946573 |
| 82 | ERBB2 | 0.73181501 |
| 83 | PDPK1 | 0.72294150 |
| 84 | MAP3K1 | 0.71466636 |
| 85 | PINK1 | 0.70219982 |
| 86 | SGK223 | 0.68105366 |
| 87 | SGK494 | 0.68105366 |
| 88 | PDGFRB | 0.66969928 |
| 89 | RET | 0.66732296 |
| 90 | KSR1 | 0.65982033 |
| 91 | ICK | 0.64980556 |
| 92 | MTOR | 0.64729656 |
| 93 | MAP3K14 | 0.63873799 |
| 94 | MAP2K1 | 0.63161912 |
| 95 | MELK | 0.63077728 |
| 96 | MAP3K13 | 0.63053262 |
| 97 | EGFR | 0.62156636 |
| 98 | PNCK | 0.61833474 |
| 99 | MAPK7 | 0.59435512 |
| 100 | TBK1 | 0.58208826 |
| 101 | EIF2AK1 | 0.57985088 |
| 102 | TRPM7 | 0.56974821 |
| 103 | PTK2 | 0.56102236 |
| 104 | SGK1 | 0.55742413 |
| 105 | PDK1 | 0.55640754 |
| 106 | PRKD1 | 0.53458237 |
| 107 | PKN1 | 0.52905214 |
| 108 | MAP3K9 | 0.51735379 |
| 109 | CSK | 0.51336888 |
| 110 | ABL2 | 0.49072468 |
| 111 | MAP3K6 | 0.48610306 |
| 112 | LRRK2 | 0.48352596 |
| 113 | CHUK | 0.48138704 |
| 114 | CAMKK1 | 0.47753641 |
| 115 | BMPR2 | 0.47131825 |
| 116 | CAMK2D | 0.44619756 |
| 117 | PRKACG | 0.44606219 |
| 118 | CAMK4 | 0.44188602 |
| 119 | NUAK1 | 0.43897856 |
| 120 | CSF1R | 0.43085078 |
| 121 | ROCK1 | 0.43073818 |
| 122 | KIT | 0.40690669 |
| 123 | FLT3 | 0.40226062 |
| 124 | IGF1R | 0.39885713 |
| 125 | MAP3K5 | 0.39131543 |
| 126 | MAP3K10 | 0.38394487 |
| 127 | LATS2 | 0.38021430 |
| 128 | FER | 0.37495809 |
| 129 | TAOK1 | 0.37437301 |
| 130 | PRKCQ | 0.36957196 |
| 131 | TIE1 | 0.36862073 |
| 132 | STK10 | 0.36736691 |
| 133 | BRD4 | 0.36714083 |
| 134 | AKT2 | 0.36473378 |
| 135 | FGFR1 | 0.35649120 |
| 136 | DYRK1B | 0.35379038 |
| 137 | CAMK2G | 0.35140307 |
| 138 | PRKCH | 0.35086388 |
| 139 | MAPK10 | 0.34592954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.88451943 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.60831010 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.18988036 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.00650586 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.76641646 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.67715864 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.62130415 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.45973805 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.44462415 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.40868325 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36302860 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.29749943 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24739251 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22931212 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.10760576 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.08488046 |
| 17 | Circadian rhythm_Homo sapiens_hsa04710 | 2.01382248 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96242848 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.93102892 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.90970503 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89038288 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.85737327 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.74697363 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.72427518 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66769399 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.59413660 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58528448 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.54353834 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49603588 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.48271298 |
| 31 | Thyroid cancer_Homo sapiens_hsa05216 | 1.45618579 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.43958743 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43900766 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.37372295 |
| 35 | Endometrial cancer_Homo sapiens_hsa05213 | 1.33478090 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29944834 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28831721 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.28133417 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.27390893 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26918215 |
| 41 | Lysine degradation_Homo sapiens_hsa00310 | 1.19681670 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.18720314 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.18296430 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.16659073 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16291897 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14935646 |
| 47 | Tight junction_Homo sapiens_hsa04530 | 1.07894943 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03892342 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02204885 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00967387 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97424395 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95151174 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93222665 |
| 54 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92405763 |
| 55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89858152 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89101371 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85123823 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.84914407 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84558336 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84212587 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83984312 |
| 62 | Prostate cancer_Homo sapiens_hsa05215 | 0.82206400 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81804278 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81456793 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.79789387 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.77115864 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76250138 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75940091 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75311179 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.69361503 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69141852 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67645820 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66390886 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62656408 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62424622 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61057406 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59848418 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59079177 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57161848 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.56892997 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.56498546 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55566475 |
| 83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53723643 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53421274 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53250677 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52528759 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51831422 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51688633 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.51456183 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51403512 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51305381 |
| 92 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50582332 |
| 93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50513993 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46253427 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45752626 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45679170 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44919983 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44756299 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.44439418 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41015098 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40883956 |
| 102 | Long-term potentiation_Homo sapiens_hsa04720 | 0.38430782 |
| 103 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37887839 |
| 104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37546437 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37251306 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37039750 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33104188 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31000976 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30129386 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.27428548 |
| 111 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26963510 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24513190 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.24393128 |
| 114 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23820972 |
| 115 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.22690519 |
| 116 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.21180653 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20802885 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19584721 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.19127851 |
| 120 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.17348033 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17266582 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16520277 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15924168 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.15007711 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.14793647 |
| 126 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14398614 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.12501828 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.11932012 |
| 129 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.10195552 |
| 130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.10068227 |
| 131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.09492453 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09126104 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.07782879 |
| 134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.07183632 |
| 135 | Other glycan degradation_Homo sapiens_hsa00511 | 0.05910549 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | 0.05378356 |
| 137 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.04666434 |

